Conferences

ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.
Share :

ASH 2009

3 Dec 2011
Cairo, Egypt

Roundtable discussion on the latest advances in multiple myeloma therapy

Prof Gordon McVie, Prof Thierry Facon, Prof Meletios Dimopoulos, Prof Heinz Ludwig
Roundtable discussion on the latest advances in multiple myeloma therapy ( Prof Gordon McVie, Prof Thierry Facon, Prof Meletios Dimopoulos, Prof Heinz Ludwig )
2 Mar 2010

ASH 2009: Bortezomib, lenalidomide, liposomal doxorubicin and dexamethasone for multiple myeloma

Prof Andrzej Jakubowiak - University of Michigan Comprehensive Cancer Center, USA
ASH 2009: Bortezomib, lenalidomide, liposomal doxorubicin and dexamethasone for multiple myeloma ( Prof Andrzej Jakubowiak - University of Michigan Comprehensive Cancer Center, USA )
1 Mar 2010

ASH 2009: New treatments for multiple myeloma

Prof Antonio Palumbo - University of Torino, Italy
ASH 2009: New treatments for multiple myeloma ( Prof Antonio Palumbo - University of Torino, Italy )
1 Mar 2010

ASH 2009: Oral panobinostat and bortezomib for relapsed multiple myeloma

Prof Jesus Fernando San-Miguel - University Hospital of Salamanca, Spain
ASH 2009: Oral panobinostat and bortezomib for relapsed multiple myeloma ( Prof Jesus Fernando San-Miguel - University Hospital of Salamanca, Spain )
1 Mar 2010

ASH 2009: New regimens for elderly multiple myeloma patients

Dr Maria-Victoria Mateos - University Hospital of Salamanca, Spain
ASH 2009: New regimens for elderly multiple myeloma patients ( Dr Maria-Victoria Mateos - University Hospital of Salamanca, Spain )
1 Mar 2010

ASH 2009: Tackling polyneuropathy associated with bortezomib

Dr Pieter Sonneveld - University Hospital Rotterdam, The Netherlands
ASH 2009: Tackling polyneuropathy associated with bortezomib ( Dr Pieter Sonneveld - University Hospital Rotterdam, The Netherlands )
1 Mar 2010

ASH 2009: Novel agents for multiple myeloma

Dr Shaji Kumar - Hematology, Mayo Clinic, Rochester, USA
ASH 2009: Novel agents for multiple myeloma ( Dr Shaji Kumar - Hematology, Mayo Clinic, Rochester, USA )
1 Mar 2010

Adult acute lymphoblastic leukaemia

Prof Anthony Goldstone - Director, North London Cancer Network
Adult acute lymphoblastic leukaemia ( Prof Anthony Goldstone - Director, North London Cancer Network )
27 Jan 2010

T-cell therapies

Dr Catherine Bollard - Baylor College of Medicine, Texas, USA
T-cell therapies ( Dr Catherine Bollard - Baylor College of Medicine, Texas, USA )
27 Jan 2010

The International Consortium on Acute Promyelocytic Leukemia

Dr Eduardo Rego - University of Sao Paulo, Brazil
The International Consortium on Acute Promyelocytic Leukemia ( Dr Eduardo Rego - University of Sao Paulo, Brazil )
27 Jan 2010

Myeloid supressor cells

Prof John Harlan - University of Washington, USA
Myeloid supressor cells ( Prof John Harlan - University of Washington, USA )
27 Jan 2010

Studies comparing treatments for lymphoma

Dr Mathias Rummel - University Hospital, Giessen, Germany
Studies comparing treatments for lymphoma ( Dr Mathias Rummel - University Hospital, Giessen, Germany )
27 Jan 2010

New target for myeloma

Dr Teru Hideshima - Principal Associate in Medicine, Harvard Medical School
New target for myeloma ( Dr Teru Hideshima - Principal Associate in Medicine, Harvard Medical School )
27 Jan 2010

Multiple myeloma news from ASH 2009

Prof Gordon McVie - ecancer managing editor
Multiple myeloma news from ASH 2009 ( Prof Gordon McVie - ecancer managing editor )
20 Jan 2010

American Society of Hematology Meeting, 5-9th Dec 2009

Prof Gordon McVie - European Institute of Oncology, Milan
American Society of Hematology Meeting, 5-9th Dec 2009 ( Prof Gordon McVie - European Institute of Oncology, Milan )
18 Jan 2010